High Growth Tech Stocks To Watch In The US March 2026

The United States market remained flat over the last week but has risen 16% over the past year, with earnings projected to grow by 16% annually in the coming years. In light of these conditions, identifying high growth tech stocks involves focusing on companies that demonstrate strong innovation and adaptability to capitalize on evolving technological trends.

Click here to see the full list of 73 stocks from our US High Growth Tech and AI Stocks screener.

Let’s uncover some gems from our specialized screener.

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Agilysys, Inc. is a company that develops and markets software-enabled solutions and services for the hospitality industry across North America, Europe, the Asia-Pacific, and India, with a market capitalization of approximately $2 billion.

Operations: Agilysys focuses on delivering software solutions to the global hospitality industry, generating $310.64 million in revenue from this segment.

Agilysys, a provider of hospitality software solutions, is demonstrating robust growth and innovation in its sector. The company’s recent deployment at Winford Resort & Casino and Rudding Park highlights its capability to enhance operational efficiency and guest service through advanced technology platforms like InfoGenesis POS and Agilysys Versa PMS. Financially, Agilysys has shown impressive performance with a 36.7% earnings growth over the past year, outpacing the software industry average of 17.2%. This growth is supported by significant investments in R&D which have enabled continuous improvement in their offerings, positioning them well for future expansion in the highly competitive tech landscape.

Simply Wall St Growth Rating: ★★★★★☆

Overview: Savara Inc. is a clinical stage biopharmaceutical company that specializes in rare respiratory diseases in the United States, with a market cap of $1.28 billion.

Operations: Savara Inc. is involved in developing treatments for rare respiratory diseases, operating as a clinical stage biopharmaceutical company in the U.S. The company currently does not generate revenue from its operations, focusing instead on advancing its pipeline of therapeutic candidates.

Savara, amid expanding its headquarters and enhancing operational capacities, confronts a challenging financial landscape with a net loss of $32.24 million in Q4 2025, consistent year-over-year. Despite these losses, the company is making significant strides in biotechnology; its MOLBREEVI for autoimmune PAP is under FDA’s priority review with potential approval by Q3 2026. This focus on specialized biologics underscores Savara’s commitment to addressing rare diseases through advanced therapies and could pivot the company towards profitability, supported by an expected annual earnings growth of 62%.

Simply Wall St Growth Rating: ★★★★★☆

Overview: Calix, Inc. operates globally, offering cloud and software platforms along with systems and services, with a market cap of approximately $3.50 billion.

Operations: Calix, Inc. generates revenue primarily through the development, marketing, and sale of communications access systems and software, totaling $1 billion. The company’s operations span across multiple regions including the United States, Europe, the Middle East, Africa, and Asia Pacific.

Calix has demonstrated robust growth, with a notable 13.1% annual revenue increase and an impressive 65.4% surge in earnings per year, outpacing the US market’s average. This performance is underpinned by strategic investments in R&D, which have grown consistently as a percentage of revenue, reflecting Calix’s commitment to innovation and technology leadership in broadband solutions. Recent developments include significant client engagements such as Blue Stream Fiber and XMission utilizing the Calix One platform to enhance connectivity across multi-dwelling units, showcasing Calix’s pivotal role in driving next-gen internet services. These initiatives not only expand its market presence but also solidify its reputation for delivering high-quality managed Wi-Fi solutions that meet evolving customer needs.

• Click through to start exploring the rest of the 70 US High Growth Tech and AI Stocks now.

• Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.

• Simply Wall St is a revolutionary app designed for long-term stock investors, it’s free and covers every market in the world.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include AGYS SVRA and CALX.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com